Condition Evidence

Stem Cells for Bone-on-Bone Knees: Which KL Grades Respond

Kellgren-Lawrence grading determines who benefits most from stem cell therapy for knee osteoarthritis. KL 2–3 responds best; KL 4 has limited evidence.

Not all knee arthritis responds equally to stem cell therapy. The Kellgren-Lawrence (KL) grading system — used worldwide to classify osteoarthritis severity on X-ray — is the single best predictor of who will benefit from regenerative treatment and who will not. Understanding your KL grade before investing in stem cell therapy can save you thousands of dollars and months of false hope.

🔍 Evidence: Level 2 — Moderate (Controlled Studies)

🏛 Regulatory Status

FDA (United States):Not FDA-approved for osteoarthritis. PRP is minimally regulated; culture-expanded MSCs are not permitted.
FDA classifies culture-expanded cells as biologics requiring IND approval.
INVIMA (Colombia):MSC therapy for OA available at INVIMA-licensed clinics. Culture-expanded cells with higher cell counts are permitted.
Colombian clinics can legally provide culture-expanded MSC injections under INVIMA oversight.
Key Takeaway

Patients with KL grade 2 and 3 osteoarthritis show the strongest response to stem cell therapy — 60–75% report meaningful improvement. KL grade 4 (bone-on-bone) patients respond poorly — under 30% meaningful improvement. A responsible clinic will tell KL 4 patients that a knee replacement is likely the better option.

KL Grade X-Ray Finding Stem Cell Response Rate Recommendation
Grade 0 Normal N/A — no OA present No treatment needed
Grade 1 Doubtful narrowing, possible osteophytes Limited data; early intervention may slow progression Consider PRP; stem cells may be premature
Grade 2 Definite osteophytes, possible joint space narrowing 60–75% meaningful improvement Best candidates for stem cell therapy
Grade 3 Multiple osteophytes, definite narrowing, sclerosis 50–65% meaningful improvement Good candidates; manage expectations for partial relief
Grade 4 Bone-on-bone, large osteophytes, severe deformity <30% meaningful improvement Knee replacement likely more appropriate; honest conversation needed
Stem Cell Response Rate by KL Grade (Published Data)
KL 2 (mild-moderate) 70 KL 3 (moderate-severe) 55 KL 4 (bone-on-bone) 25
Approximate percentage of patients reporting meaningful (>50%) improvement in WOMAC or VAS pain scores at 12 months. Multiple published studies.

What "Meaningful Improvement" Means

In clinical studies, "meaningful improvement" typically means a 50% or greater reduction in pain scores (VAS or WOMAC), improved walking distance or stair-climbing ability, reduced need for pain medication, and delayed or avoided joint replacement surgery. This is not a cure — it is a clinically significant reduction in symptoms that improves quality of life.

The Honest KL 4 Conversation

Any clinic that offers stem cell therapy for KL grade 4 knees without a frank discussion of the limited evidence is prioritizing revenue over patient care. The honest message is: total knee replacement has the strongest evidence for KL 4 osteoarthritis and remains the gold standard. Stem cell therapy may provide temporary symptom relief for KL 4 patients who are not surgical candidates (due to age, health status, or personal preference), but expectations must be realistic.

For KL-grade-specific consultations, connect through colombiastemcelltreatment.com.

Ready to Explore Your Options?

Connect with us for an honest assessment of whether stem cell therapy is appropriate for your condition.

💬 Chat on WhatsApp

Explore Colombia's Medical Tourism Network